ANTIBIOTIC SUBSTANCE GALACARDINS A AND B

PURPOSE:To obtain an antimicrobial agent for infectious diseases caused by Gram-positive bacteria by culturing a microorganism, belonging to actinomyces and capable of producing galacardins A (G-A) and B (G-B). CONSTITUTION:An antibiotic substance galacardin A produced by culturing a strain SANK 642...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: INUKAI MASATOSHI, TAKEUCHI MICHIKO, ENOKIDA RYUZO, KAGASAKI TAKESHI, NAGAKI HIDEMI, TAKAHASHI HIDEJI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator INUKAI MASATOSHI
TAKEUCHI MICHIKO
ENOKIDA RYUZO
KAGASAKI TAKESHI
NAGAKI HIDEMI
TAKAHASHI HIDEJI
description PURPOSE:To obtain an antimicrobial agent for infectious diseases caused by Gram-positive bacteria by culturing a microorganism, belonging to actinomyces and capable of producing galacardins A (G-A) and B (G-B). CONSTITUTION:An antibiotic substance galacardin A produced by culturing a strain SANK 64289 (FERM P-10940) in a culture medium containing glucose, etc., providing a culture, centrifuging and purifying the resultant culture and having the following physico-chemical properties. Properties of the substance; amphoteric water-soluble white powder. Specific rotatory power [alpha]-38.7 deg. (c, 1.00, H2O). Elementary analysis value%; C, 50.55; H, 5.62; N, 5.06; Cl, 2.39; F, 1.16 (provided that trifluoroacetic acid and water are partially contained). Molecular formula; C101H121O46N9Cl2. Molecular weight; 2265 (measured by an FAB- MAS method). Hydrolysis; producing monodechlorovancomycinic acid, etc., as amino acids by acid hydrolysis. Ultraviolet absorption spectrum; lambdamaxnm (E) 280nm (39.6). Soluble in water, methanol, etc. The galacardin B is similarly produced. The resultant G-A and G-B, as necessary, contained to produce an antimicrobial agent.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH0383594A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH0383594A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH0383594A3</originalsourceid><addsrcrecordid>eNrjZNBw9AvxdPL0D_F0VggOdQoOcfRzdlVwd_RxdHYMcvH0C1ZwVHD0c1Fw4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8V4BHgbGFsamliaOxkQoAQCoCyOM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIBIOTIC SUBSTANCE GALACARDINS A AND B</title><source>esp@cenet</source><creator>INUKAI MASATOSHI ; TAKEUCHI MICHIKO ; ENOKIDA RYUZO ; KAGASAKI TAKESHI ; NAGAKI HIDEMI ; TAKAHASHI HIDEJI</creator><creatorcontrib>INUKAI MASATOSHI ; TAKEUCHI MICHIKO ; ENOKIDA RYUZO ; KAGASAKI TAKESHI ; NAGAKI HIDEMI ; TAKAHASHI HIDEJI</creatorcontrib><description>PURPOSE:To obtain an antimicrobial agent for infectious diseases caused by Gram-positive bacteria by culturing a microorganism, belonging to actinomyces and capable of producing galacardins A (G-A) and B (G-B). CONSTITUTION:An antibiotic substance galacardin A produced by culturing a strain SANK 64289 (FERM P-10940) in a culture medium containing glucose, etc., providing a culture, centrifuging and purifying the resultant culture and having the following physico-chemical properties. Properties of the substance; amphoteric water-soluble white powder. Specific rotatory power [alpha]-38.7 deg. (c, 1.00, H2O). Elementary analysis value%; C, 50.55; H, 5.62; N, 5.06; Cl, 2.39; F, 1.16 (provided that trifluoroacetic acid and water are partially contained). Molecular formula; C101H121O46N9Cl2. Molecular weight; 2265 (measured by an FAB- MAS method). Hydrolysis; producing monodechlorovancomycinic acid, etc., as amino acids by acid hydrolysis. Ultraviolet absorption spectrum; lambdamaxnm (E) 280nm (39.6). Soluble in water, methanol, etc. The galacardin B is similarly produced. The resultant G-A and G-B, as necessary, contained to produce an antimicrobial agent.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1991</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19910409&amp;DB=EPODOC&amp;CC=JP&amp;NR=H0383594A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19910409&amp;DB=EPODOC&amp;CC=JP&amp;NR=H0383594A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>INUKAI MASATOSHI</creatorcontrib><creatorcontrib>TAKEUCHI MICHIKO</creatorcontrib><creatorcontrib>ENOKIDA RYUZO</creatorcontrib><creatorcontrib>KAGASAKI TAKESHI</creatorcontrib><creatorcontrib>NAGAKI HIDEMI</creatorcontrib><creatorcontrib>TAKAHASHI HIDEJI</creatorcontrib><title>ANTIBIOTIC SUBSTANCE GALACARDINS A AND B</title><description>PURPOSE:To obtain an antimicrobial agent for infectious diseases caused by Gram-positive bacteria by culturing a microorganism, belonging to actinomyces and capable of producing galacardins A (G-A) and B (G-B). CONSTITUTION:An antibiotic substance galacardin A produced by culturing a strain SANK 64289 (FERM P-10940) in a culture medium containing glucose, etc., providing a culture, centrifuging and purifying the resultant culture and having the following physico-chemical properties. Properties of the substance; amphoteric water-soluble white powder. Specific rotatory power [alpha]-38.7 deg. (c, 1.00, H2O). Elementary analysis value%; C, 50.55; H, 5.62; N, 5.06; Cl, 2.39; F, 1.16 (provided that trifluoroacetic acid and water are partially contained). Molecular formula; C101H121O46N9Cl2. Molecular weight; 2265 (measured by an FAB- MAS method). Hydrolysis; producing monodechlorovancomycinic acid, etc., as amino acids by acid hydrolysis. Ultraviolet absorption spectrum; lambdamaxnm (E) 280nm (39.6). Soluble in water, methanol, etc. The galacardin B is similarly produced. The resultant G-A and G-B, as necessary, contained to produce an antimicrobial agent.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1991</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBw9AvxdPL0D_F0VggOdQoOcfRzdlVwd_RxdHYMcvH0C1ZwVHD0c1Fw4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8V4BHgbGFsamliaOxkQoAQCoCyOM</recordid><startdate>19910409</startdate><enddate>19910409</enddate><creator>INUKAI MASATOSHI</creator><creator>TAKEUCHI MICHIKO</creator><creator>ENOKIDA RYUZO</creator><creator>KAGASAKI TAKESHI</creator><creator>NAGAKI HIDEMI</creator><creator>TAKAHASHI HIDEJI</creator><scope>EVB</scope></search><sort><creationdate>19910409</creationdate><title>ANTIBIOTIC SUBSTANCE GALACARDINS A AND B</title><author>INUKAI MASATOSHI ; TAKEUCHI MICHIKO ; ENOKIDA RYUZO ; KAGASAKI TAKESHI ; NAGAKI HIDEMI ; TAKAHASHI HIDEJI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH0383594A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1991</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>INUKAI MASATOSHI</creatorcontrib><creatorcontrib>TAKEUCHI MICHIKO</creatorcontrib><creatorcontrib>ENOKIDA RYUZO</creatorcontrib><creatorcontrib>KAGASAKI TAKESHI</creatorcontrib><creatorcontrib>NAGAKI HIDEMI</creatorcontrib><creatorcontrib>TAKAHASHI HIDEJI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>INUKAI MASATOSHI</au><au>TAKEUCHI MICHIKO</au><au>ENOKIDA RYUZO</au><au>KAGASAKI TAKESHI</au><au>NAGAKI HIDEMI</au><au>TAKAHASHI HIDEJI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIBIOTIC SUBSTANCE GALACARDINS A AND B</title><date>1991-04-09</date><risdate>1991</risdate><abstract>PURPOSE:To obtain an antimicrobial agent for infectious diseases caused by Gram-positive bacteria by culturing a microorganism, belonging to actinomyces and capable of producing galacardins A (G-A) and B (G-B). CONSTITUTION:An antibiotic substance galacardin A produced by culturing a strain SANK 64289 (FERM P-10940) in a culture medium containing glucose, etc., providing a culture, centrifuging and purifying the resultant culture and having the following physico-chemical properties. Properties of the substance; amphoteric water-soluble white powder. Specific rotatory power [alpha]-38.7 deg. (c, 1.00, H2O). Elementary analysis value%; C, 50.55; H, 5.62; N, 5.06; Cl, 2.39; F, 1.16 (provided that trifluoroacetic acid and water are partially contained). Molecular formula; C101H121O46N9Cl2. Molecular weight; 2265 (measured by an FAB- MAS method). Hydrolysis; producing monodechlorovancomycinic acid, etc., as amino acids by acid hydrolysis. Ultraviolet absorption spectrum; lambdamaxnm (E) 280nm (39.6). Soluble in water, methanol, etc. The galacardin B is similarly produced. The resultant G-A and G-B, as necessary, contained to produce an antimicrobial agent.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JPH0383594A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title ANTIBIOTIC SUBSTANCE GALACARDINS A AND B
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T07%3A32%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=INUKAI%20MASATOSHI&rft.date=1991-04-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH0383594A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true